Avidity Biosciences Inc
RNA
Get informed when a big investor buys or sells
+ FollowMarket Cap$211.08M
Close$
$-11.33
191.9% downside
Current Fair Value
191.9% downsideOvervalued by 191.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $211.08 Million |
|---|---|
| Enterprise Value | $-44,741,365.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.48 |
| Beta | 0.37 |
| Outstanding Shares | 17,105,643 |
Return
| Return on Equity | -250.10% |
|---|---|
| Return on Assets | -200.26% |
| Return on Invested Capital | -222.14% |
Valuation & Multiples
| P/E Ratio | -4.62 |
|---|---|
| PEG | 5.4 |
| Price to Sales | 6.17 |
| Price to Book Ratio | 0.95 |
| Enterprise Value to Revenue | -1.22 |
| Enterprise Value to EBIT | 0.07 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.27 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-1.42
Average shareholder expectationRevenue Estimate
$666,667
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-1.16
Average shareholder expectationRevenue Estimate
$666,667
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 4.1800▼ 1310.75% |
|---|---|
| Total Calls | 5,000▼ 92.42% |
| Total Puts | 20,900▼ 98.17% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 13.16%▼ 73.65% |
|---|---|
| Total Invested | $30.29M▼ 84.75% |
| Investors Holding | 47▼ 120.00% |
ESG Score
No data